Concepedia

L. Kong

LK

Statistics

Publications

7

Citations

1K

H-Index

7

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

L. Kong is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medical microbiology, microbiology, and new antifungal agents.

Publications per year

1995–2001

7

Publications

7

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 319 citations · Full text

, , +17

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

K Bartizal, Christopher Gill, George K. Abruzzo et al. · Antimicrobial Agents and Chemotherapy · 1997 · 312 citations · Full text

, , +14

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1997 · 245 citations · Full text

, , +17

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1995 · 79 citations · Full text

, , +17

Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

M. Francisca Vicente, Angeles Cabello, Gonzalo Platas et al. · Journal of Applied Microbiology · 2001 · 53 citations

, , +17

1–5 of 7